Eastgate Biotech Corp.

OTC: ETBI · Healthcare · Medical - Pharmaceuticals

PublicHQ Toronto, NVCIK 0001099574Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 34

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ workforce scale, filing timeliness

Methodology →

Revenue TTM

$44.1k

Rev growth YoY (TTM)

-53.0%

Net income (FY)

-$3.0M

Employees

Market cap

$6.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$3.0M-$3.0M2016

Operating income-$2.6M-$2.6M2016

Total assets$0$02016

Liabilities$4.6M$4.6M2016

Equity-$4.6M-$4.6M2016

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Eastgate Biotech Corp. earned -$3.0M in FY2016 net income.

Peers · Healthcare

Curative Biotechnology, Inc.——BriaCell Therapeutics Corp.——Nextleaf Solutions Ltd.57C Pulmatrix, Inc.46D

Key facts

CEORosella C. Perri

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersToronto, NV

ExchangeOTC: ETBI

Employees2

IPO date2014-03-05

Latest filings

8-K2019-09-16 10-Q2019-03-04 10-Q2018-12-18 10-Q2018-08-17 8-K2018-06-08 8-K2018-05-07 10-K2018-03-01 8-K2017-05-22

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.